This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Avanci optional, efficient for Chinese carmakers, executive says, amid outcry over high rates

By MLex Staff ( March 7, 2025, 04:41 GMT | Insight) -- Patent pool Avanci is solely an option for Chinese automakers seeking licenses for essential cellular technologies used in connected vehicles, Laurie Fitzgerald, president of Avanci Vehicle business, told a conference in Shenzhen. The official said that even after becoming participating licensees on the Avanci platform, Chinese operators always have the option of negotiating with patent owners individually.Patent pool Avanci is solely an option for Chinese automakers seeking licenses for essential cellular technologies used in connected vehicles, Laurie Fitzgerald, president of Avanci Vehicle business, told a conference* in Shenzhen. The official said that even after becoming participating licensees on the Avanci platform, Chinese operators always have the option of negotiating with patent owners individually....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections